Molecular basis for the presence of glycosylated onco-foetal fibronectin in oral carcinomas: the production of glycosylated onco-foetal fibronectin by carcinoma cells

Research output: Contribution to journalJournal articleResearchpeer-review

Glycosylated onco-foetal fibronectin (GOF) deposited in the stroma of oral squamous cell carcinomas correlates with survival. One of the two polypeptide GalNAc-transferases, GalNAc-T3 or GalNAc-T6, is required for the biosynthesis of GOF by the initiation of a unique O-glycan in the alternative spliced IIICS region. Using cell culture experiments, immunohistochemical staining of primary tissue, and RT-PCR of tumour cells isolated by laser capture techniques we have examined the molecular basis for the production of GOF in oral carcinomas. Immuno-histochemical investigation confirmed the stromal deposition of GOF in oral carcinomas. However, neither GalNAc-T3 nor GalNAc-T6 could be detected in stromal fibroblasts. In contrast both transferases were present in the oral squamous carcinoma cells, suggesting that GOF is produced by the oral cancer cells and not only the stromal cells. RT-PCR analysis of RNA isolated from carcinoma cells provided further support for this conclusion by demonstrating in-splicing of the alternative spliced IIICS domain in GOF.

Original languageEnglish
JournalOral Oncology
Volume43
Issue number3
Pages (from-to)301-9
Number of pages9
ISSN1368-8375
DOIs
Publication statusPublished - Mar 2007

    Research areas

  • Actins, Biocompatible Materials, Carcinoma, Squamous Cell, Cell Line, Tumor, Cells, Cultured, Collagen, Drug Combinations, Fibroblasts, Fibronectins, Glycosylation, Humans, Immunohistochemistry, Keratinocytes, Laminin, Mouth Neoplasms, Muscle, Smooth, Proteoglycans, Sialyltransferases

ID: 119538186